137 related articles for article (PubMed ID: 35552246)
1.
Subramaniam RM; Duan FM; Romanoff J; Yu JQ; Bartel T; Dehdashti F; Intenzo CM; Solnes L; Sicks J; Stack BC; Lowe VJ
J Nucl Med; 2022 Dec; 63(12):1887-1890. PubMed ID: 35552246
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Trial of [
Lowe VJ; Duan F; Subramaniam RM; Sicks JD; Romanoff J; Bartel T; Yu JQM; Nussenbaum B; Richmon J; Arnold CD; Cognetti D; Stack BC
J Clin Oncol; 2019 Jul; 37(20):1704-1712. PubMed ID: 30768363
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
Jackson T; Chung MK; Mercier G; Ozonoff A; Subramaniam RM
Nucl Med Commun; 2012 Mar; 33(3):305-12. PubMed ID: 22227560
[TBL] [Abstract][Full Text] [Related]
6. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
7. Assessment of outcomes with delayed (18)F-FDG PET-CT response assessment in head and neck squamous cell carcinoma.
Slevin F; Subesinghe M; Ramasamy S; Sen M; Scarsbrook AF; Prestwich RJ
Br J Radiol; 2015 Aug; 88(1052):20140592. PubMed ID: 26081447
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of 2-[(18)F] Fluoro-2-deoxy-D-glucose Positron Emission Tomography-Computed Tomography Scan Carried out During and After Radiation Therapy for Head and Neck Cancer Using Visual Therapy Response Interpretation Criteria.
Min M; Lin P; Lee M; Ho Shon I; Lin M; Forstner D; Tieu MT; Chicco A; Bray V; Fowler A
Clin Oncol (R Coll Radiol); 2016 Jun; 28(6):393-401. PubMed ID: 26782837
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
10. Impact of combined (18)F-FDG PET/CT in head and neck tumours.
Syed R; Bomanji JB; Nagabhushan N; Hughes S; Kayani I; Groves A; Gacinovic S; Hydes N; Visvikis D; Copland C; Ell PJ
Br J Cancer; 2005 Mar; 92(6):1046-50. PubMed ID: 15770212
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
12. Preoperative
Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of diffusion-weighted imaging and
Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
[TBL] [Abstract][Full Text] [Related]
16. PET/MR versus PET/CT for locoregional staging of oropharyngeal squamous cell cancer.
Flygare L; Erdogan ST; Söderkvist K
Acta Radiol; 2023 May; 64(5):1865-1872. PubMed ID: 36464816
[TBL] [Abstract][Full Text] [Related]
17. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
18. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L
Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
[TBL] [Abstract][Full Text] [Related]
20. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
